Transfer of an Unfilled Electronic Adderall Prescription from California
A patient moves from California to Honolulu and calls a Hawaii pharmacy to transfer an electronic prescription for Adderall XR 20 mg, quantity 30, issued by a California prescriber. The prescription has not been filled; it is still active at the California pharmacy. The patient says the California pharmacy told her it can send it. The Hawaii pharmacist receives a faxed copy of the prescription from the California pharmacy, along with a transfer form. The Hawaii pharmacist is not sure whether Schedule II prescriptions can be transferred and whether the prescriber must be licensed in Hawaii. The patient is a new patient and has no records at the Hawaii pharmacy. The pharmacist also notes the prescription is for a stimulant and the patient is paying cash.
1. Under federal law, may the Hawaii pharmacy accept the transfer of this unfilled electronic Schedule II prescription? Explain the conditions.
Read the worked answer
Yes, if the prescription is truly unfilled and electronic and the transfer is done under the DEA’s 2023 final rule on transfers of electronic prescriptions for Schedules II–V for initial filling. That rule permits a pharmacy to transfer an unfilled electronic prescription for a Schedule II–V controlled substance to another pharmacy for initial filling, one time only. Both pharmacies must be DEA-registered, and the transfer must be communicated between pharmacists or authorized personnel.
The transfer must be documented with the transferring and receiving pharmacy names, addresses, and DEA numbers; the patient; the prescriber; the prescription details; the date; and the identity of the transferring pharmacist. The receiving pharmacist must verify the prescription’s validity and resolve red flags. The rule does not permit transfer of a paper Schedule II prescription or of a prescription that has already been filled. Hawaii law may impose additional requirements, including whether the California prescriber is authorized to issue a controlled-substance prescription for a patient in Hawaii; the pharmacist must verify that before dispensing.
2. What documentation must the Hawaii pharmacist create, and what must she verify about the prescriber?
Read the worked answer
The Hawaii pharmacist should document the one-time transfer, the source pharmacy, the DEA numbers of both pharmacies, the prescriber’s name and DEA registration, the prescription details, the date and time, and the names of the pharmacists involved. She should also document that the prescription was unfilled at the time of transfer.
She must verify the prescriber’s DEA registration and the prescriber’s authority to prescribe for a patient located in Hawaii. If Hawaii requires a Hawaii license or nonresident registration for controlled-substance prescribers, the California prescriber must satisfy that requirement or the prescription cannot be filled. The pharmacist should also check the Hawaii PMP, verify the patient’s identity, consider the cash-payment red flag, and counsel on stimulant risks. If any red flag remains unresolved, the pharmacist should not dispense.
3. If the prescription had already been filled once at the California pharmacy, would the answer change? Why?
Read the worked answer
Yes. The federal transfer rule applies to an unfilled electronic prescription for initial filling. If the prescription had already been filled once, it is no longer eligible for transfer under that rule. A Schedule II prescription cannot be refilled, and a filled Schedule II prescription cannot be transferred to a new pharmacy for a repeat fill. The patient would need a new prescription from a prescriber authorized to prescribe in Hawaii, and the pharmacist would need to verify the new prescription independently, including PMP review and resolution of any early-fill or multiple-prescriber concerns.